X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (36) 36
female (30) 30
male (29) 29
index medicus (28) 28
adult (22) 22
middle aged (20) 20
oncology (20) 20
hematology (18) 18
chemotherapy (15) 15
aged (13) 13
prognosis (13) 13
disease (11) 11
antineoplastic combined chemotherapy protocols - therapeutic use (10) 10
treatment outcome (10) 10
aged, 80 and over (8) 8
lymphoma (8) 8
lymphomas (8) 8
retrospective studies (8) 8
adolescent (7) 7
cancer (7) 7
survival (7) 7
analysis (6) 6
disease-free survival (6) 6
multiple myeloma (6) 6
risk factors (6) 6
therapy (6) 6
abridged index medicus (5) 5
care and treatment (5) 5
classification (5) 5
follow-up studies (5) 5
hodgkin disease - drug therapy (5) 5
non-hodgkins-lymphoma (5) 5
positron-emission tomography (5) 5
research (5) 5
rituximab (5) 5
stem cell transplantation (5) 5
tomography (5) 5
abvd (4) 4
b-cell lymphoma (4) 4
case report (4) 4
clinical neurology (4) 4
combined modality therapy (4) 4
doxorubicin - therapeutic use (4) 4
drug administration schedule (4) 4
hodgkin disease - diagnostic imaging (4) 4
hodgkin's disease (4) 4
management (4) 4
medicine & public health (4) 4
mycosis-fungoides (4) 4
patients (4) 4
positron emission tomography (4) 4
prospective studies (4) 4
survival analysis (4) 4
young adult (4) 4
antineoplastic combined chemotherapy protocols - administration & dosage (3) 3
biopsy (3) 3
bleomycin - therapeutic use (3) 3
cyclophosphamide - administration & dosage (3) 3
cyclophosphamide - therapeutic use (3) 3
cytokines (3) 3
dacarbazine - therapeutic use (3) 3
dermatology (3) 3
doxorubicin - administration & dosage (3) 3
expression (3) 3
genetic aspects (3) 3
hematology, oncology and palliative medicine (3) 3
hodgkin disease - mortality (3) 3
hodgkin disease - pathology (3) 3
liver (3) 3
lymphoma, non-hodgkin - therapy (3) 3
macop-b (3) 3
magnetic resonance imaging (3) 3
medical prognosis (3) 3
minimal residual disease (3) 3
multiple myeloma - pathology (3) 3
multiple myeloma - therapy (3) 3
multiple-myeloma (3) 3
non-hodgkin's lymphomas (3) 3
nuclear medicine (3) 3
patient outcomes (3) 3
pet (3) 3
pet imaging (3) 3
philadelphia-chromosome (3) 3
positron-emission-tomography (3) 3
prednisone - administration & dosage (3) 3
prednisone - therapeutic use (3) 3
radiology, nuclear medicine & medical imaging (3) 3
risk (3) 3
stem cells (3) 3
t-cell lymphoma (3) 3
time factors (3) 3
tomography, x-ray computed (3) 3
transplantation (3) 3
transplants & implants (3) 3
usage (3) 3
vinblastine - therapeutic use (3) 3
vincristine - administration & dosage (3) 3
vincristine - therapeutic use (3) 3
activation (2) 2
antigens (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International journal of molecular sciences, ISSN 1422-0067, 03/2019, Volume 20, Issue 6, p. 1373
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2018, Volume 13, Issue 7, p. e0200221
Journal Article
Blood, ISSN 0006-4971, 11/2013, Volume 122, Issue 20, pp. 3511 - 3520
Journal Article
by Mohty, Mohamad and Terpos, Evangelos and Mateos, Maria-Victoria and Cavo, Michele and Lejniece, Sandra and Beksac, Meral and Bekadja, Mohamed Amine and Legiec, Wojciech and Dimopoulos, Meletios and Stankovic, Svetlana and Durán, Maria Soledad and De Stefano, Valerio and Corso, Alessandro and Kochkareva, Yulia and Laane, Edward and Berthou, Christian and Salwender, Hans and Masliak, Zvenyslava and Pečeliūnas, Valdas and Willenbacher, Wolfgang and Silva, João and Louw, Vernon and Nemet, Damir and Borbényi, Zita and Abadi, Uri and Pedersen, Robert Schou and Černelč, Peter and Potamianou, Anna and Couturier, Catherine and Feys, Caroline and Thoret-Bauchet, Florence and Boccadoro, Mario and Bekadja, Mohamed and Hamladji, Rose-Marie and Ali, Hocine Ait and Hamdi, Selma and Touhami, Hadj and Mansour, Nourredine Sidi and Linkesch, Werner and Abildgaard, Niels and Hein, Marju and Eveillard, Jean Richard and Yamani, Abderrazak el and Moreau, Philippe and Sanhes, Laurence and Lepeu, Gérard and Laribi, Kamel and Jourdan, Eric and Fitoussi, Olivier and Allangba, Olivier and Fleury, Joël and Escoffre, Martine and Benramdane, Riad and Cartron, Guillaume and Dine, Gérard and Legouffe, Eric and Harich, Hanns-Detlev and Illmer, Thomas and Dörfel, Steffen and Hannig, Carla Verena and Koenigsmann, Michael and Prange-Krex, Gabriele and Tamm, Ingo and Zeller, Wolfgang and Maasberg, Michael and Schlag, Rudolf and Klausmann, Martine and Uhlig, Jens and Alkemper, Burkhard and Schütz, Stefan and Tessen, Hans-Werner and Mohr, Benno and Schmidt, Peter and Heinrich, Bernhard and Hebart, Holger and Seipelt, Gernot and Zoeller, Thomas and Heits, Frank and Müller-Naendrup, Clemens and Hansen, Richard and Repp, Roland and Von Weikersthal, Ludwig Fischer and Schmits, Rudolf and Heßling, Jörg and Krammer-Steiner, B and Janzen, Viktor and Schauer, Michael and Grüner, Marcus W and Kisro, Jens and Denzlinger, Claudio and Freier, Werner and Junghanss, Christian and Görner, Martin and Laichinger, Katharina and Ostermann, Helmut and Dürk, Heinz and Hess, Georg and Reich, Gernot and Matsouka, Panagiota and Pouli, Anastasia and ... and EMMOS Investigators
Clinical Lymphoma, Myeloma and Leukemia, ISSN 2152-2650, 10/2018, Volume 18, Issue 10, pp. e401 - e419
Multiple myeloma (MM) remains an incurable disease, with little information available on its management in real-world clinical practice. The results of the... 
Stem cell transplantation | Observational study | Bortezomib | Routine practice | Global | UNITED-STATES | SURVIVAL | GUIDELINES | INDUCTION | PLUS DEXAMETHASONE | ONCOLOGY | TREATMENT PATTERNS | THERAPIES | STEM-CELL TRANSPLANTATION | HEMATOLOGY
Journal Article
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 4397 - 4397
Abstract Background Altough the inhibitor of Bruton's tyrosyne kinase (BTK) ibrutinib has transformed the management of patients with CLL obtaining decreased... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 3617 - 3617
Abstract Introduction Erythrocytosis is characterized by persistently raised hemoglobin (HB) and hematocrit (Ht) levels. Differential diagnosis includes... 
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 3050 - 3050
Abstract The neutrophil/lymphocyte ratio (N/L) at diagnosis has been shown to be a prognostic factor for survival in solid tumors. An increase in the... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 4396 - 4396
Abstract Background Ibrutinib, inhibitor of Bruton's tyrosyne kinase (BTK), demonstrated exceptional activity both in untreated and relapsed/refractory CLL... 
Journal Article
Mediterranean Journal of Hematology and Infectious Diseases, ISSN 2035-3006, 10/2019, Volume 11, Issue 1, p. e2019065
Background: although bronchoalveolar lavage (BAL) measurements of galactomannan antigen (GM) seems to be more sensitive than serum testing to detect invasive... 
bronchoalveolar lavage, galactomannan antigen, pulmonary aspergillosis, hematologic malignancies, thrombocytopenia
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 3204 - 3204
Abstract Trisomy 12 is the third most common cytogenetic abnormality in CLL with several distinguishing features including abormal morphology, high prevalence... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 5634 - 5634
Abstract Introduction .Treatment of multiple myeloma (MM) patients (pts) has radically changed over the last years following the introduction of next... 
Journal Article
European Journal of Haematology, ISSN 0902-4441, 07/2018, Volume 101, Issue 1, pp. 78 - 85
Objective The most typical cytogenetic aberration in myelodysplastic syndromes is del(5q), which, when isolated, is associated with refractory anaemia and good... 
lenalidomide | registry study | del(5q) | myelodysplastic syndromes | AML PROGRESSION | SURVIVAL | RISK | TRANSFUSION-DEPENDENT PATIENTS | MUTATIONS | HEMATOLOGY | MDS | Genetic research | Cytogenetics | Care and treatment | Angiogenesis inhibitors | Anemia | Myelodysplastic syndromes | Clonal deletion | Hematology | Remission | Chromosome deletion | Chromosome 5 | Myelodysplastic syndrome
Journal Article